<DOC>
	<DOCNO>NCT02189967</DOCNO>
	<brief_summary>In randomize multicentric phase II study investigate whether accelerated postoperative radiotherapy ( 7 fraction per week , 2 Gy single dose ) may improve locoregional tumour control non-small cell lung cancer ( NSCLC ) comparison conventional fractionation ( 5 fraction per week , 2 Gy single dose ) .</brief_summary>
	<brief_title>Postoperative Radiotherapy Non-small Cell Lung Cancer : Accelerated v . Conventional Fractionation</brief_title>
	<detailed_description>This study randomize multicentric trial . Within study accelerate irradiation schedule ( 7 fraction per week , 2 Gy single dose ) compare currently use conventional fractionation schedule ( 5 fraction per week , 2 Gy single dose ) postoperative radiotherapy patient NSCLC . The primary endpoint locoregional tumour control 36 month . Secondary endpoint overall survival patient , local recurrence-free distant metastases-free survival 36 month , acute late toxicity well quality life treatment method .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>histologically confirm nonsmall cell lung cancer previous tumor resection curative intention postoperative indication irradiation ( &gt; pN1 and/ R1 ) exclusion distant metastasis ( M0 ) age &gt; 18 year good general condition ( ECOG performance status 0 1 ) write informed consent appropriate compliance ensure close followup woman childbearing age : adequate contraception histologically confirm small cell lung cancer distant metastasis write informed consent lack cooperation relate therapy followup previous ( &lt; 5 year ) concomitant malignant disease ( exception : malignant disease , likely heal influenced therapy follow nonsmall cell lung cancer , e.g . carcinoma insitu , basaliomas , early skin cancer ) previous radiotherapy thorax lower neck region pregnancy lactation participation another intervention study complete followup intervention study . Exceptions psychological study , supportive observation study , previous therapy nonsmall cell lung cancer accordance guideline participation radiotherapy study exclude trial protocol previous study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>accelerate fractionation</keyword>
	<keyword>conventional fractionation</keyword>
	<keyword>postoperative</keyword>
</DOC>